Navigation Links
Angiotech To Participate In The American Academy Of Ophthalmology (AAO) 2007 Annual Meeting
Date:11/8/2007

Introducing SharpGuard(TM) Microsurgical Guarded Knives For Use In

Ophthalmic Surgery

VANCOUVER, Nov. 8 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it plans to exhibit its SharpGuard(TM) product line as well as all of its Sharpoint(TM) brand ophthalmic disposable surgical instruments at the upcoming American Academy of Ophthalmology (AAO) annual meeting.

About the SharpGuard(TM) Guarded Knives Product Line

The SharpGuard(TM) product line is comprised of microsurgical guarded knives for use in ophthalmic surgery. Key features of the SharpGuard(TM) product line include:

- Guarded sheath designed to eliminate or minimize sharps injuries

- Sharpoint(TM) premium quality microsurgical blades manufactured by

proprietary Infinite Edge(TM) technology process

- Ergonomic grip designed for precise control and comfort

- Designed to comply with OSHA bloodborne pathogens regulations

Angiotech will host Booth # 2411 at the AAO annual meeting in New Orleans, LA, taking place from November 10-13, 2007.

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at http://www.angiotech.com.

SHARPGUARD(TM), SHARPOINT(TM) and INFINITE EDGE(TM) are trademarks of

Surgical Specialties Corporation, a wholly-owned subsidiary of Angiotech

Pharmaceuticals, Inc.

(C)2007 Angiotech Pharmaceuticals, Inc. (C)2007 Surgical Specialties

Corporation. All Rights Reserved.

CONTACT: Jodi Regts, Senior Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, jregts@angio.com


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Angiotech to participate in CIBC 18th Annual Healthcare Conference
2. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
3. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
4. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
5. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
6. Cincinnati Adoption Agency Invited to Participate in Values Voter Presidential Debate
7. Dental Researchers Participate in Global Awareness Initiative
8. @ease Spa is Proud to Participate in Spa Week
9. Synova Healthcare to Participate in Womens Health Care in the New Millennium Conference, as Retail Distribution for the Fem-V(R) Test Kit Expands
10. Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast
11. AMERIGROUP to Participate in National Disability Mentoring Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: